International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 302-311 doi: 10.5281/zenodo.16730405
Original Article
Icteric Plasma in Healthy Donors to Transfuse or to Discard
 ,
 ,
Published
Aug. 2, 2025
Abstract

Background: Icteric plasma, a yellowish color of plasma caused by elevated levels of bilirubin, is a frequent cause of blood donations especially by Hurricane Gilbert maladies. The significance of the occurrence and clinical consequence of icteric plasma is often surrounded with controversy especially on its safety during blood transfusion.

Methods: It was a rate-based prospective observational study carried out in the Ruxmaniben Deepchand Gardi Medical College, Ujjain Blood Bank, between December 2017 and June 2019. The purpose of the study was to establish the occurrence of mild hyperbilirubinemia in otherwise-healthy blood donors. Whole blood, tested as sero-negative, was screened to icteric plasma, and several types of biochemical tests were performed, which include the liver functions tests, and markers of hemolysis.

Results: A total of 8,971 donations were examined during 18 months period, and 66 icteric bags were registered (1.355). Icteric plasma was highest among the 26-35 years group (62.1%) age group and lowest among 0-15 years group (0.5%). Confirmatory tests by biochemists revealed that although the total bilirubin was high, the rest of the profiles were normal inclusive of liver enzymes, hemoglobin, and protein levels hence the plausible benign nature of the discoloration.

Conclusion: The majority of the population that has because of Gilbert syndrome the problem of icteric plasma is really a major problem in the blood donation process, whereby the greatest in this age group/range is between the age groups of 26-35 years. Although there are already regulatory guidelines regarding the rejection of icteric plasma the present study allows to rethink the policies concerning re-use of icteric plasma, which does not seem to produce any serious risk to the recipient, at least when no liver dysfunction, hemolysis, or infections are present

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
2446 Views
382 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved